Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS? TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* ...

Smith & Nephew reported its first-quarter 2025 earnings, showcasing a revenue of $1.4 billion, with underlying growth at 3.1%, surpassing its guidance. The company faced a 1.2% reported growth due ...

UK medical products maker Smith+Nephew beat first-quarter revenue growth expectations and maintained its full-year sales and profit margin forecasts on Wednesday, despite the potential impact of U ...

On Friday, HSBC analysts downgraded Smith & Nephew PLC (LON: SN:LN) (NYSE: SNN) stock from Buy to Hold, adjusting the price target to GBP10.70 from the previous GBP11.60.The revision comes despite ...

Shares in medical firm Smith & Nephew leapt on Tuesday as ongoing restructuring delivered strong full-year sales and profits. At £11.37 per share, Smith & Nephew’s share price was 9% higher on ...

Smith & Nephew's stock has underperformed, driven by ongoing market share losses in hip and knee markets and pricing pressures in China, raising concerns about its ongoing multiyear restructuring ...

MEMPHIS, Tenn. — Smith+Nephew has confirmed that they will be laying off over 150 Memphis employees. The company’s orthopedic division employs over 2,000 people in the city. The company… ...

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in costs for the decision. In 2022, ...

Price Performance. Shares of Smith & Nephew have increased 9.5% so far this year compared with 5.4% rise of the industry.The S&P 500 has witnessed an 11.7% rise in the same time frame.